Clinical Trial Update: A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis [Phase 2]

View source ↗

Summary

A Phase 2, double-blind, randomized, placebo-controlled study evaluating topical VDO for herpes labialis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Labialis

Drugs mentioned

• VDO

Snippet

Sponsor: Yung Shin Pharm. Ind. Co., Ltd. | Conditions: Herpes Labialis | Phase 2 | Status: COMPLETED